JPMorgan Chase & Co’s Corbus Pharmaceuticals CRBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.78K | Sell |
|
|||||
|
2025
Q1 | $30.4K | Buy |
|
|||||
|
2024
Q4 | $62.3K | Sell |
|
|||||
|
2024
Q3 | $114K | Buy |
|
|||||
|
2024
Q2 | $196K | Sell |
|
|||||
|
2024
Q1 | $2.42M | Buy |
|
|||||
|
2023
Q4 | $3.28K | Sell |
|
|||||
|
2023
Q3 | $11.5K | Buy |
|
|||||
|
2023
Q2 | $1.47K | Sell |
|
|||||
|
2023
Q1 | $1K | Sell |
|
|||||
|
2022
Q4 | $5K | Sell |
|
|||||
|
2022
Q3 | $7K | Sell |
|
|||||
|
2022
Q2 | $14K | Sell |
|
|||||
|
2022
Q1 | $55K | Sell |
|
|||||
|
2021
Q4 | $66K | Buy |
|
|||||
|
2021
Q3 | $35K | Sell |
|
|||||
|
2021
Q2 | $342K | Sell |
|
|||||
|
2021
Q1 | $617K | Buy |
|
|||||
|
2020
Q4 | $323K | Buy |
|
|||||
|
2020
Q3 | $61K | Buy |
|
|||||
|
2020
Q2 | $195K | Sell |
|
|||||
|
2020
Q1 | $1.23M | Buy |
|
|||||
|
2019
Q4 | $987K | Buy |
|
|||||
|
2019
Q3 | $188K | Buy |
|
|||||
|
2019
Q2 | $132K | Buy |
|
|||||
|
2019
Q1 | $113K | Buy |
|
|||||
|
2018
Q4 | $74K | Buy |
|
|||||
|
2018
Q3 | $87K | Buy |
|
|||||
|
2018
Q2 | $51K | Buy |
|
|||||
|
2018
Q1 | $60K | Sell |
|
|||||
|
2017
Q4 | $74K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $3K | Buy |
|